Found: 6
Select item for more details and to access through your institution.
Truncated O-GalNAc glycans impact on fundamental signaling pathways in pancreatic cancer.
- Published in:
- Glycobiology, 2024, v. 34, n. 6, p. 1, doi. 10.1093/glycob/cwab088
- By:
- Publication type:
- Article
Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 6, p. 1618, doi. 10.1002/ijc.32567
- By:
- Publication type:
- Article
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 9, p. 2065, doi. 10.1002/ijc.28214
- By:
- Publication type:
- Article
Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice.
- Published in:
- Experimental & Molecular Medicine EMM, 2018, v. 50, n. 10, p. 1, doi. 10.1038/s12276-018-0157-3
- By:
- Publication type:
- Article
Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
- Published in:
- Molecular Cancer, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12943-015-0386-1
- By:
- Publication type:
- Article